MYSOLINE PRIMIDONE TABLETS 250MG DIN 00002631
Status: Cancelled Post Market
Holder: AYERST VETERINARY LABORATORIES
Health Canada record
| Active ingredient(s) | PRIMIDONE 250 MG |
|---|
| Dosage form | Tablet |
|---|
| Route | Oral |
|---|
| Schedule | PRESCRIPTION |
|---|
| Class | Veterinary |
|---|
| ATC | |
|---|
| Original market date | 31-Dec-1965 |
|---|
| Current status date | 14-Aug-2001 |
|---|
| Source | Health Canada DPD |
|---|
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PRIMIDONE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 00396761 | PRIMIDONE | AA PHARMA INC | Tablet | PRIMIDONE 250 MG | Marketed |
| 00399310 | PRIMIDONE | AA PHARMA INC | Tablet | PRIMIDONE 125 MG | Marketed |
| 02042355 | MYSOLINE 250MG TAB | ELAN PHARMACEUTICALS INC | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
| 02042363 | MYSOLINE PEDIATRIC CHEWABLE TABLETS 125MG | ELAN PHARMACEUTICALS INC | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00002623 | MYSOLINE TAB 125MG | AYERST LABORATORIES | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00563714 | PRIMIDONE 125 TAB | PRO DOC LIMITEE | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00563706 | PRIMIDONE 250 TAB | PRO DOC LIMITEE | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
| 00576700 | SERTAN TAB 125MG | PHARMASCIENCE INC | Tablet | PRIMIDONE 125 MG | Cancelled Post Market |
| 00576719 | SERTAN TAB 250MG | PHARMASCIENCE INC | Tablet | PRIMIDONE 250 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 6846 | 1998-04-17 | New Drug Submission (NDS) | |
International API supply for PRIMIDONE
4 valid EDQM Certificates of Suitability from 4 holders. 5 active FDA Drug Master Files.
Request a quote for MYSOLINE PRIMIDONE TABLETS 250MG
How to read a Canadian DIN record